Today, the White House Office of Science and Technology Policy (OSTP) updated U.S. policy guidance to make the results of taxpayer-supported research immediately available to the American public at no cost. In a memorandum to federal departments and agencies, Dr. Alondra Nelson, the head of OSTP, delivered guidance for agencies to update their public access policies as soon as possible to make…
Read More
More than 2 years in the making, a massive bill that Congress completed this week aims high: It envisions a 5-year, $280 billion investment to keep the United States ahead of China in a global competition for technological preeminence. The CHIPS and Science Act, passed yesterday by the House of Representatives and on Wednesday by the Senate, will result in…
Read More
President Joe Biden last week got his wish for a new agency to fund high-risk, cutting-edge biomedical research when Congress created the Advanced Research Projects Agency for Health (ARPA-H) and gave it a $1 billion startup investment. That’s a fraction of the $6.5 billion Biden had proposed, but advocates say it’s plenty to launch ARPA-H. The 2022 spending bill does
Read More
In January 2023, the US National Institutes of Health (NIH) will begin requiring most of the 300,000 researchers and 2,500 institutions it funds annually to include a data-management plan in their grant applications — and to eventually make their data publicly available. Researchers who spoke to Nature largely applaud the open-science principles underlying the policy — and the global example it sets.…
Read More
President Joe Biden’s administration last week ordered federal agencies to draft uniform policies describing the outside sources of funding that scientists must disclose when they apply for federal grants, and the penalties for failing to do so. Research groups welcome the directive, but wish it had also specified what kinds of foreign collaborations might get a scientist in trouble. The…
Read More
The U.S. Food and Drug Administration authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age. The authorization was based on the FDA’s thorough and transparent evaluation of the data that included input from independent advisory committee experts who overwhelmingly voted in favor of making the vaccine…
Read More
The United States must perform a careful balancing act to secure federally funded research against improper interference from China and other foreign governments without shutting down valuable international scientific research collaborations, MIT Vice President for Research Maria T. Zuber said this week in testimony before Congress.   Speaking at a virtual hearing held by two subcommittees of the U.S. House Science Committee,…
Read More
The US government is investing heavily to breed more monkeys at the national facilities that house primates for biomedical research, Nature has learnt. The goal is to offset an ongoing shortage of these animals, which grew worse in 2020 as scientists tested scores of COVID-19 vaccines and treatments on primates before trials began in people. To make room for more monkeys, the…
Read More
US President Joe Biden’s administration wants to create a US$6.5-billion agency to accelerate innovations in health and medicine — and revealed new details about the unit last month1. Dubbed ARPA-Health (ARPA-H), it is the latest in a line of global science agencies now being modelled on the renowned US Defense Advanced Research Projects Agency (DARPA), whose work a generation ago…
Read More
It was a good day for science in the U.S. House of Representatives. In back-to-back votes last night, members overwhelmingly approved two bills that would authorize massive spending increases at the National Science Foundation (NSF) and the Department of Energy’s (DOE) Office of Science. One calls for more than doubling NSF’s current annual budget of $8.5 billion to $17.9 billion…
Read More